Please login or register first to view this content.
News
NEWS
Latest News
Could COPD Serve as a Marker of Cardiovascular Morbidity, Mortality?
Cardiovascular Disease Found to Raise End-Stage Renal Disease Risk
Do Patients Care About the Cultural Competence of Healthcare Providers?
Tool Developed to Assess Long-Term CVD Risk, Benefit of Lipid-Lowering Intervention
Presence of Hyperlipidemia May Lower Mortality After MI, ADHF
Dose-Dependent Reduction of Lipoprotein(a) With APO(a)-LRx
Time-Restricted Eating May Improve Metabolic Syndrome
Lipidome Module Associated With Markers of Atherosclerosis, Osteoporosis
HDL Cholesterol Can Be Used to Monitor Triglycerides, Remnant Cholesterol
Drug News from MPR
Provider Gaps Identified in Cardiopulmonary Care
Rilonacept Gets Breakthrough Therapy Status for Recurrent Pericarditis
Cardiometabolic Effects of Gender-Affirming Hormone Therapy in Transgender Youth
Oral Suspension Formulation of Amlodipine Now Available
How I Treat My Patients With Sacubitril/Valsartan for Heart Failure With Reduced Ejection Fraction
Rivaroxaban Appears Safe, Effective for Pediatric Acute VTE
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
Alirocumab Approved by FDA to Reduce Serious Cardiovascular Event Risk
Is There Evidence to Support Kombucha Health Claims in Humans?
FDA Approves First Generic Versions of Ambrisentan for PAH
Want to read more?
Next post in General Cardiology
